Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient-reported outcomes from the APOLLO trial

  1. Terpos, E.
  2. Dimopoulos, M.A.
  3. Boccadoro, M.
  4. Delimpasi, S.
  5. Beksac, M.
  6. Katodritou, E.
  7. Moreau, P.
  8. Pompa, A.
  9. Symeonidis, A.
  10. Bila, J.
  11. Oriol, A.
  12. Mateos, M.-V.
  13. Einsele, H.
  14. Orfanidis, I.
  15. Gries, K.S.
  16. Fastenau, J.
  17. Liu, K.
  18. He, J.
  19. Kampfenkel, T.
  20. Qiu, Y.
  21. Amin, H.
  22. Carson, R.
  23. Sonneveld, P.
Aldizkaria:
American Journal of Hematology

ISSN: 1096-8652 0361-8609

Argitalpen urtea: 2022

Alea: 97

Zenbakia: 4

Orrialdeak: 481-490

Mota: Artikulua

DOI: 10.1002/AJH.26480 GOOGLE SCHOLAR